Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
US7250442B2 · kind B2 · utility
6Cited by
15References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2003 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Jan 22, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation, particularly congestive heart failure, comprising administering to a patient in need thereof an effective amount of a compound of the formula: I or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.